Advertisement

CRISPR-mediated TCR replacement generates superior anticancer transgenic T-cells

Mateusz Legut, Garry Dolton, Afsar Ali Mian, Oliver Ottmann and Andrew Sewell

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted May 30, 2017
  • Accepted November 4, 2017
  • Published online November 9, 2017.


Contributors 
  • Mateusz Legut, 1 Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom;
  • Garry Dolton, 2 Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, United Kingdom;
  • Afsar Ali Mian, 3 Department of Haematology, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom
  • Oliver Ottmann, 3 Department of Haematology, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom
  • Andrew Sewell, 1 Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output